FDA product code JBF: Glucose-6-Phosphate Dehydrogenase (Erythrocytic), Screening
JBF is the FDA product code for glucose-6-phosphate dehydrogenase (erythrocytic), screening. It is a Class II device, regulated under 21 CFR 864.7360 and reviewed by the Hematology panel. FDA has cleared 5 510(k) submissions under JBF, 1 in the last five years, from 5 different applicants. The average 510(k) review took 401 days (median 295). FDA has posted 1 recall for JBF devices.
Classification
| Field | Value |
|---|---|
| Device name | Glucose-6-Phosphate Dehydrogenase (Erythrocytic), Screening |
| Device class | Class II |
| Regulation | 21 CFR 864.7360 |
| Review panel | HE — Hematology |
| Medical specialty | Hematology |
| Premarket route | 510(k) |
| Third-party 510(k) review eligible | Yes |
510(k) clearances per year for JBF
| Year | Clearances | Avg. review days |
|---|---|---|
| 2022 | 1 | 876 |
Compare with all 510(k) review times · Search every JBF clearance
Top JBF applicants
| Applicant | Clearances | Latest |
|---|---|---|
| Baebies, Inc. | 1 | 2022-09-14 |
| Alere Scarborough, Inc. | 1 | 2016-06-17 |
| Binax, Inc. | 1 | 2008-10-23 |
| Pointe Scientific, Inc., | 1 | 2003-03-31 |
| Sigma Diagnostics, Inc. | 1 | 1995-06-29 |
Most recent JBF clearances
| 510(k) | Applicant | Device | Decision date | Review days |
|---|---|---|---|---|
| K201049 | Baebies, Inc. | FINDER G6PD | 2022-09-14 | 876 |
| K161364 | Alere Scarborough, Inc. | BinaxNOW G6PD Test | 2016-06-17 | 31 |
| K080003 | Binax, Inc. | BINAXNOW G6PD TEST | 2008-10-23 | 295 |
| K024006 | Pointe Scientific, Inc., | G6PDH, GLUCOSE-6-PHOSHATE DEHYDROGENASE | 2003-03-31 | 117 |
| K933934 | Sigma Diagnostics, Inc. | GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY SCREENING TEST KIT NO. 202-A | 1995-06-29 | 687 |
Recalls for JBF devices
1 product recalls in 1 recall events; 0 initiated in the last five years and 0 still open. Most recent: 2015-05-19.
Frequently asked questions
What is FDA product code JBF?
JBF is the FDA product code for glucose-6-phosphate dehydrogenase (erythrocytic), screening. It is a Class II device, regulated under 21 CFR 864.7360 and reviewed by the Hematology panel.
What device class is JBF?
Class II, regulation 21 CFR 864.7360. Typical premarket route: 510(k).
How long does a 510(k) take for product code JBF?
Across 5 cleared submissions the average was 401 days from receipt to decision (median 295).
Which companies have the most JBF clearances?
Baebies, Inc. (1); Alere Scarborough, Inc. (1); Binax, Inc. (1); Pointe Scientific, Inc., (1); Sigma Diagnostics, Inc. (1).
Have JBF devices been recalled?
Yes: 1 product recalls across 1 recall events; the most recent began 2015-05-19.
Next steps
- Run an FDA pathway report with predicate devices for product code JBF
- Run a recall and safety report across every JBF manufacturer
- Watch product code JBF for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Hematology product codes · FDA product code lookup · 510(k) database search · 510(k) review times